Story perspectives

New PRIMA System Restores Vision for 84% in Trial

10/27/2025

42 6

Summary

Story summary

Researchers from University College London and Moorfields Eye Hospital developed the PRIMA System for geographic atrophy.
In a clinical trial, 84% regained the ability to recognize letters and numbers.
The device is activated by augmented-reality glasses and converts visuals into brain signals.
Some patients experienced complications, and a quality-of-life assessment showed no significant improvement.
The PRIMA System could benefit Singapore’s aging population by addressing vision loss.

1 of 1

Story summary

Researchers from University College London and Moorfields Eye Hospital developed the PRIMA System for geographic atrophy.
In a clinical trial, 84% regained the ability to recognize letters and numbers.
The device is activated by augmented-reality glasses and converts visuals into brain signals.
Some patients experienced complications, and a quality-of-life assessment showed no significant improvement.
The PRIMA System could benefit Singapore’s aging population by addressing vision loss.